| Market revenue in 2022 | USD 27.5 million |
| Market revenue in 2030 | USD 43.9 million |
| Growth rate | 6% (CAGR from 2022 to 2030) |
| Largest segment | Open angle glaucoma |
| Fastest growing segment | Open Angle Glaucoma |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Open Angle Glaucoma, Angle Closure Glaucoma, Others Disease Type |
| Key market players worldwide | Pfizer Inc, Santen Pharmaceutical Co Ltd, Novartis AG ADR, Alcon Inc, Akron Biotechnology, AbbVie Inc, Bausch & Lomb Corp, Teva Pharmaceutical Industries Ltd |
Publish Date: Jul 10, 2024
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Novartis AG ADR | View profile | 76,057 | Lichtstrasse 35, Basel, Switzerland, 4056 | www.novartis.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37,851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | www.tevapharm.com |
| AbbVie Inc | View profile | 50,000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | www.abbvieinvestor.com |
| Pfizer Inc | View profile | 88,000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | www.pfizer.com |
| Alcon Inc | View profile | 25,315 | Chemin de Blandonnet 8, Royce Bedward, Vernier, Geneva, Switzerland, 1214 | www.alcon.com |
| Bausch & Lomb Corp | View profile | 13,300 | 520 Applewood Crescent, Vaughan, ON, Canada, L4K 4B4 | www.bausch.com |
| Santen Pharmaceutical Co Ltd | View profile | 1,807 | Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka, Japan, 530-8552 | www.santen.co.jp |
| Akron Biotechnology | View profile | 11-50 | Boca Raton, Florida, United States, North America | www.akronbiotech.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Glaucoma Market Outlook, 2030 will help companies and investors design strategic landscapes.
Open Angle Glaucoma was the largest segment with a revenue share of 76.73% in 2022.
Horizon Databook has segmented the Uae glaucoma market , 2030 based on open angle glaucoma, angle closure glaucoma, others disease type covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE glaucoma market report, including forecasts for subscribers. This country databook contains high-level insights into UAE glaucoma market report from 2018 to 2030, including revenue numbers, major trends, and company profiles.